- Tytuł:
- Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
- Autorzy:
- Źródło:
- In The Lancet Oncology April 2020 21(4):519-530
Czasopismo naukowe